new tirzepatide for weight loss vs. Semaglutide: Which Medication Is Right You? Zepbound (Tirzepatide): A Q&A on

It also works on another hormone called GIP

Tirzepatide simultaneously activates GIP and GLP-1 receptors, producing complementary metabolic effects

Each state decides which medications are included under its prescription drug coverage, so whether your Wegovy prescription is covered depends entirely on where you live

I had given up on my health. With Wegovy, her health problems faded away one by one: Her blood sugar went down, she stopped needing a CPAP machine to sleep, and her periods became regular

GLP-1 Drug Market Research Report: Size, Share, Trend Analysis By Drug Type (Short-acting, Long-acting, Dual-action), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Indication (Type 2 Diabetes, Obesity, Cardiovascular Diseases), By Administration Route (Subcutaneous Injection, Oral, Inhalation) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035 ID: MRFR/HC/20411-HCR 128 Pages Last Updated: May 15, 2026 GLP-1 Drug Market Market Size Forecast Period2025 - 2035 CAGR (2025 - 2035)13.17% 2024 Market Size$ 10.77 Billion 2025 Market Size$ 12.19 Billion 2035 Market Size$ 42 Billion Key Players Companies such as Novo Nordisk Eli Lilly Sanofi Boehringer Ingelheim AstraZeneca Merck & Co